2006Zhongguo xiong-xin xueguan waike linchuang zazhiRequires access

hVEGF165/pcDNA3.1 Expression in Neonate Mice Myocardial Cells

Zhou Zheng-chun

Open publisher page 0 citations

Abstract

Objective To investigate the transfection and expression of recombinant plasmid human vascular endothelial growth factor 165/pcDNA3.1(hVEGF165/pcDNA3.1) in myocardial cells,and to build foundation for gene therapy and cell therapy of coronary artery disease(CAD).Methods Myocardial cells were cultured in vitro and transfected by hVEGF165/pcDNA3.1 with liposome;then transient expressed protein was detected by reverse transcriptase-polymerase chain reaction(RT-PCR),immunochemistry and Western blotting.Results A strap as hVEGF165 was obtained by RT-PCR,the protein of hVEGF165 was found in myocardial cells by immunochemistry and in supernatant by Western blotting.Conclusion The recombinant plasmid hVEGF165/pcDNA3.1 can be expressed in myocardial cells,and may be used in studying CAD by gene therapy and cell transplantation.

About this research paper

What this paper is about

Objective To investigate the transfection and expression of recombinant plasmid human vascular endothelial growth factor 165/pcDNA3.1(hVEGF165/pcDNA3.1) in myocardial cells,and to build foundation for gene therapy and cell therapy of coronary artery disease(CAD).Methods Myocardial cells were cultured in vitro and transfected by hVEGF165/pcDNA3.1 with liposome;then transient expressed protein was detected by reverse transcriptase-polymerase chain reaction(RT-PCR),immunochemistry and Western blotting.Results A strap as hVEGF165 was obtained by RT-PCR,the protein of hVEGF165 was found in myocardial cells by immunochemistry and in supernatant by Western blotting.Conclusion The recombinant plasmid hVEGF165/pcDNA3.1 can be expressed in myocardial cells,and may be used in studying CAD by gene therapy and cell transplantation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the transfection and expression of recombinant plasmid human vascular endothelial growth factor 165/pcDNA3.1(hVEGF165/pcDNA3.1) in myocardial cells,and to build foundation for gene therapy and cell therapy of coronary artery disease(CAD).Methods Myocardial cells were cultured in vitro and transfected by hVEGF165/pcDNA3.1 with liposome;then transient expressed protein was detected by reverse transcriptase-polymerase chain reaction(RT-PCR),immunochemistry and Western blotting.Results A strap as hVEGF165 was obtained by RT-PCR,the protein of hVEGF165 was found in myocardial cells by immunochemistry and in supernatant by Western blotting.Conclusion The recombinant plasmid hVEGF165/pcDNA3.1 can be expressed in myocardial cells,and may be used in studying CAD by gene therapy and cell transplantation.

Key concepts: Immunochemistry, Transfection, Molecular biology, Recombinant DNA, Blot, Plasmid, Transplantation, Flow cytometry

Related papers

Back to paper searchBrowse research topicsOriginal source
hVEGF165/pcDNA3.1 Expression in Neonate Mice Myocardial Cells — Research Paper | ScholarLens